how were glp 1 drugs discovered GLP-1 receptor assay: drug discovery in the metabolic field Discovery of GLP-1–Based Drugs for

Cinchonine Promoted Insulin Secretion and Oral Administration of Cinchonine Reduced Blood Glucose in C57BL/6 Mice Insulin deficiency is a critical pathogenesis of T2DM, and the effect of cinchonine on insulin secretion was investigated for the first time

Since these agents are resistant to rapid enzymatic degradation, they maintain prolonged metabolic activity

Statistics Statistical analysis was performed using SPSS 26.0 (SPSS Inc, Chicago, IL, USA)

Burley, and Kathleen Aertgeerts

This small peptide is eliminated by the kidneys and has a plasma half-life of approximately 3 hours, requiring twice-daily subcutaneous injections